Valuation : Artivion, Inc.

Market Cap 1.31B 1.12B 1.05B 963M 1.81B 125B 1.82B 12.51B 4.88B 62.97B 4.9B 4.79B 209B P/E 2026 *
-99.1x
P/E 2027 * 92.7x
Enterprise Value 1.31B 1.12B 1.05B 963M 1.81B 125B 1.82B 12.51B 4.88B 62.97B 4.9B 4.79B 209B EV / Sales 2026 *
2.66x
EV / Sales 2027 * 2.4x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day+0.37%
1 week-4.67%
Current month-0.22%
1 month-3.25%
3 months+20.64%
6 months-30.56%
Current year-41.31%
1 week 26.02
Extreme 26.02
27.42
1 month 25.79
Extreme 25.7875
30.14
Current year 19.16
Extreme 19.16
46.84
1 year 19.16
Extreme 19.16
48.25
3 years 12.16
Extreme 12.1582
48.25
5 years 9.64
Extreme 9.64
48.25
10 years 9.64
Extreme 9.64
48.25
Manager TitleAgeSince
Chief Executive Officer 59 2014-09-01
Director of Finance/CFO 53 2023-12-03
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 2003-11-30
Director/Board Member 66 2003-11-30
Director/Board Member 61 2012-04-30
Date Insider Type Main position Quantity % Market Cap.
8/19/26 Sell

Chief Executive Officer

-70,000 0.1442%
8/14/26 Sell

General Counsel

-616 0.0013%
8/14/26 Sell

Chief Financial Officer

-715 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%-4.67%-39.06%+52.80% 1.31B
+0.79%-3.58%-15.22%+7.72% 195B
+1.40%-2.27%-1.70%+10.84% 117B
+0.25%+1.25%+10.43%+80.01% 61.45B
+0.74%-1.29%-1.79%-32.39% 51.62B
+0.80%-1.18%+27.69%+52.27% 51.03B
+1.71%-1.65%+20.55%-12.18% 34.27B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+36.66%-17.51% 23.75B
-0.91%-3.06%-6.22%+14.03% 23.41B
Average +0.45%-1.68%+3.48%+17.29% 58.92B
Weighted average by Cap. +0.76%-1.96%+0.32%+14.77%

Financials

2026 *2027 *
Net sales 490M 423M 396M 362M 681M 46.87B 684M 4.7B 1.83B 23.66B 1.84B 1.8B 78.45B 543M 468M 439M 401M 755M 51.92B 757M 5.21B 2.03B 26.21B 2.04B 2B 86.9B
Net income -12.09M -10.41M -9.76M -8.91M -16.79M -1.16B -16.85M -116M -45.2M -583M -45.38M -44.39M -1.93B 14.8M 12.75M 11.95M 10.91M 20.56M 1.41B 20.62M 142M 55.33M 714M 55.55M 54.34M 2.37B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change Volume
26-08-28 $26.77 +0.37% 466,495
26-08-27 $26.67 -1.95% 440,843
26-08-26 $27.20 +3.11% 609,017
26-08-25 $26.38 -1.90% 735,678
26-08-24 $26.89 -4.24% 1,036,009
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
26.77USD
Average target price
42.15USD
Spread / Average Target
+57.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock